Nutrition drink may ease throat pain during lung cancer radiation
NCT ID NCT06840704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether a daily nutritional drink (Oral Impact®) can reduce severe throat and esophagus inflammation caused by chest radiation in lung cancer patients. About 121 adults with lung cancer who need radiation will drink two bottles a day during and for three weeks after treatment. The study compares how many patients develop serious swallowing pain versus those not receiving the drink.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Oral immunonutrition (Oral Impact®)
What this could lead to
If it works, this could offer a simple, non-drug way to prevent painful swallowing during lung cancer radiation, improving quality of life.
What could go wrong
This is a mid-stage trial with 121 participants, so results may not apply to everyone. The drink may not reduce esophagitis significantly, and some people might not tolerate it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First People's Hospital of Chenzhou
RECRUITINGChenzhou, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Fisrt Affilated Hospital of University of South China
RECRUITINGHengyang, Hunan, 421001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Third Xiangya Hospital, Central South University
RECRUITINGChangsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangya Hospital of Central South University,
RECRUITINGChangsha, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yueyang Central Hospital
RECRUITINGYueyang, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••